Shigeno, Kazuyuki <br/><br/>
Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: updated outcomes of the phase II study and postremission therapies.  [electronic resource] 

 -  International journal of hematology  Oct 2005 
 - 224-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0925-5710 
<br/><br/><label>Standard No.: </label>10.1532/IJH97.05044  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Arsenic Trioxide<br/>Arsenicals--administration & dosage<br/>Bone Marrow--pathology<br/>Female<br/>Humans<br/>Japan<br/>Leukemia, Promyelocytic, Acute--complications<br/>Male<br/>Middle Aged<br/>Neoplasm Proteins--biosynthesis<br/>Oncogene Proteins, Fusion--biosynthesis<br/>Oxides--administration & dosage<br/>Recurrence<br/>Remission Induction<br/>Treatment Outcome